Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

The neurotransmitters of sleep.

Siegel JM.

J Clin Psychiatry. 2004;65 Suppl 16:4-7. Review.

2.

Roles of orexin/hypocretin in regulation of sleep/wakefulness and energy homeostasis.

Sakurai T.

Sleep Med Rev. 2005 Aug;9(4):231-41. Review.

PMID:
15961331
3.

From waking to sleeping: neuronal and chemical substrates.

Jones BE.

Trends Pharmacol Sci. 2005 Nov;26(11):578-86. Epub 2005 Sep 23. Review. Erratum in: Trends Pharmacol Sci. 2006 Apr;27(4):189.

PMID:
16183137
4.

Different neuronal phenotypes in the lateral hypothalamus and their role in sleep and wakefulness.

Gerashchenko D, Shiromani PJ.

Mol Neurobiol. 2004 Feb;29(1):41-59. Review.

PMID:
15034222
5.

Orexin neuronal circuitry: role in the regulation of sleep and wakefulness.

Ohno K, Sakurai T.

Front Neuroendocrinol. 2008 Jan;29(1):70-87. Epub 2007 Aug 29. Review.

PMID:
17910982
6.

Roles of the hypocretin/orexins in the regulation of sleep and wakefulness.

Terao A, Haruyama T, Kimura K.

Jpn J Vet Res. 2008 Jan;55(2-3):75-83. Review.

PMID:
18318109
7.

Non-sleep effects of hypocretin/orexin.

Samson WK, Taylor MM, Ferguson AV.

Sleep Med Rev. 2005 Aug;9(4):243-52. Epub 2005 Apr 22. Review.

PMID:
16036174
8.

Orexin/hypocretin modulation of the basal forebrain cholinergic system: insights from in vivo microdialysis studies.

Fadel J, Frederick-Duus D.

Pharmacol Biochem Behav. 2008 Aug;90(2):156-62. doi: 10.1016/j.pbb.2008.01.008. Epub 2008 Jan 19. Review.

PMID:
18281084
9.

Orexin/hypocretin plays a role in the response to physiological disequilibrium.

Sinton CM.

Sleep Med Rev. 2011 Jun;15(3):197-207. doi: 10.1016/j.smrv.2010.12.003. Epub 2011 Jan 26. Review.

PMID:
21269851
10.

The hypothalamic peptidergic system, hypocretin/orexin and vigilance control.

Nishino S.

Neuropeptides. 2007 Jun;41(3):117-33. Epub 2007 Mar 21. Review.

PMID:
17376528
11.

Underlying brain mechanisms that regulate sleep-wakefulness cycles.

Gvilia I.

Int Rev Neurobiol. 2010;93:1-21. doi: 10.1016/S0074-7742(10)93001-8. Review.

PMID:
20969999
12.

Modulation of cortical activation and behavioral arousal by cholinergic and orexinergic systems.

Jones BE.

Ann N Y Acad Sci. 2008;1129:26-34. doi: 10.1196/annals.1417.026. Review.

PMID:
18591466
13.

Arousal systems.

Jones BE.

Front Biosci. 2003 May 1;8:s438-51. Review.

PMID:
12700104
14.

Orexins (hypocretins): their role in appetite and arousal.

Preti A.

Curr Opin Investig Drugs. 2002 Aug;3(8):1199-206. Review.

PMID:
12211415
15.

Hypocretins (orexins): clinical impact of the discovery of a neurotransmitter.

Baumann CR, Bassetti CL.

Sleep Med Rev. 2005 Aug;9(4):253-68. Review.

PMID:
15979356
16.

Hypothalamic regulation of sleep and arousal.

Szymusiak R, McGinty D.

Ann N Y Acad Sci. 2008;1129:275-86. doi: 10.1196/annals.1417.027. Review.

PMID:
18591488
17.

[Advances in the study of histaminergic systems and sleep-wake regulation].

Liu TY, Hong ZY, Qu WM, Huang ZL.

Yao Xue Xue Bao. 2011 Mar;46(3):247-52. Review. Chinese.

PMID:
21626776
18.

The physiological role of orexins.

Martynska L, Wolinska-Witort E, Chmielowska M, Bik W, Baranowska B.

Neuro Endocrinol Lett. 2005 Aug;26(4):289-92. Review.

PMID:
16135995
19.

Metabolic state signalling through central hypocretin/orexin neurons.

Burdakov D, Alexopoulos H.

J Cell Mol Med. 2005 Oct-Dec;9(4):795-803. Review.

20.

Neurotransmitters and sleep.

Mendelson WB.

J Clin Psychiatry. 2001;62 Suppl 10:5-8. Review.

Supplemental Content

Support Center